カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

結核予防接種の世界市場2022：免疫ワクチン、治療ワクチン

◆英語タイトル：Global Tuberculosis Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO19677 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：101 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

結核予防接種市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の結核予防接種の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

結核予防接種市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・免疫ワクチン、治療ワクチン

用途別セグメントは次のように区分されます。
・自己調達、ユニセフ、その他

世界の結核予防接種市場の主要な市場プレーヤーは以下のとおりです。
・Merck、Japan BCG Lab、Serum Institute of India、AJ Vaccines、BioFarma、GreenSignal Bio Pharma、China National Biotec、Biomed Lublin、Taj Pharmaceuticals、Ataulpho de Paiva、IVAC – Institute of Vaccines and Medical Biologicals、Queen Saovabha Mem. Inst、Microgen

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、結核予防接種製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な結核予防接種メーカーの企業概要、2019年～2022年までの結核予防接種の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な結核予防接種メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別結核予防接種の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの結核予防接種の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での結核予防接種市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および結核予防接種の産業チェーンを掲載しています。
・第13、14、15章では、結核予防接種の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 結核予防接種の概要
- 種類別分析（2017年vs2021年vs2028年）：免疫ワクチン、治療ワクチン
- 用途別分析（2017年vs2021年vs2028年）：自己調達、ユニセフ、その他
- 世界の結核予防接種市場規模・予測
- 世界の結核予防接種生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Merck、Japan BCG Lab、Serum Institute of India、AJ Vaccines、BioFarma、GreenSignal Bio Pharma、China National Biotec、Biomed Lublin、Taj Pharmaceuticals、Ataulpho de Paiva、IVAC – Institute of Vaccines and Medical Biologicals、Queen Saovabha Mem. Inst、Microgen
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：免疫ワクチン、治療ワクチン
・用途別分析2017年-2028年：自己調達、ユニセフ、その他
・結核予防接種の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・結核予防接種のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・結核予防接種のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・結核予防接種の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・結核予防接種の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Tuberculosis Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tuberculosis Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Self-Procurement accounting for % of the Tuberculosis Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immune Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tuberculosis Vaccination include Merck, Japan BCG Lab, Serum Institute of India, AJ Vaccines, and BioFarma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tuberculosis Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Immune Vaccine
Therapy Vaccine
Market segment by Application can be divided into
Self-Procurement
UNICEF
Other
The key market players for global Tuberculosis Vaccination market are listed below:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tuberculosis Vaccination product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tuberculosis Vaccination, with price, sales, revenue and global market share of Tuberculosis Vaccination from 2019 to 2022.
Chapter 3, the Tuberculosis Vaccination competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuberculosis Vaccination breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tuberculosis Vaccination market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tuberculosis Vaccination.
Chapter 13, 14, and 15, to describe Tuberculosis Vaccination sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Tuberculosis Vaccination Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tuberculosis Vaccination Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Immune Vaccine
1.2.3 Therapy Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Tuberculosis Vaccination Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Self-Procurement
1.3.3 UNICEF
1.3.4 Other
1.4 Global Tuberculosis Vaccination Market Size & Forecast
1.4.1 Global Tuberculosis Vaccination Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Tuberculosis Vaccination Sales in Volume (2017-2028)
1.4.3 Global Tuberculosis Vaccination Price (2017-2028)
1.5 Global Tuberculosis Vaccination Production Capacity Analysis
1.5.1 Global Tuberculosis Vaccination Total Production Capacity (2017-2028)
1.5.2 Global Tuberculosis Vaccination Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tuberculosis Vaccination Market Drivers
1.6.2 Tuberculosis Vaccination Market Restraints
1.6.3 Tuberculosis Vaccination Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Tuberculosis Vaccination Product and Services
2.1.4 Merck Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Japan BCG Lab
2.2.1 Japan BCG Lab Details
2.2.2 Japan BCG Lab Major Business
2.2.3 Japan BCG Lab Tuberculosis Vaccination Product and Services
2.2.4 Japan BCG Lab Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Serum Institute of India
2.3.1 Serum Institute of India Details
2.3.2 Serum Institute of India Major Business
2.3.3 Serum Institute of India Tuberculosis Vaccination Product and Services
2.3.4 Serum Institute of India Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 AJ Vaccines
2.4.1 AJ Vaccines Details
2.4.2 AJ Vaccines Major Business
2.4.3 AJ Vaccines Tuberculosis Vaccination Product and Services
2.4.4 AJ Vaccines Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 BioFarma
2.5.1 BioFarma Details
2.5.2 BioFarma Major Business
2.5.3 BioFarma Tuberculosis Vaccination Product and Services
2.5.4 BioFarma Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GreenSignal Bio Pharma
2.6.1 GreenSignal Bio Pharma Details
2.6.2 GreenSignal Bio Pharma Major Business
2.6.3 GreenSignal Bio Pharma Tuberculosis Vaccination Product and Services
2.6.4 GreenSignal Bio Pharma Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 China National Biotec
2.7.1 China National Biotec Details
2.7.2 China National Biotec Major Business
2.7.3 China National Biotec Tuberculosis Vaccination Product and Services
2.7.4 China National Biotec Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Biomed Lublin
2.8.1 Biomed Lublin Details
2.8.2 Biomed Lublin Major Business
2.8.3 Biomed Lublin Tuberculosis Vaccination Product and Services
2.8.4 Biomed Lublin Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Taj Pharmaceuticals
2.9.1 Taj Pharmaceuticals Details
2.9.2 Taj Pharmaceuticals Major Business
2.9.3 Taj Pharmaceuticals Tuberculosis Vaccination Product and Services
2.9.4 Taj Pharmaceuticals Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Ataulpho de Paiva
2.10.1 Ataulpho de Paiva Details
2.10.2 Ataulpho de Paiva Major Business
2.10.3 Ataulpho de Paiva Tuberculosis Vaccination Product and Services
2.10.4 Ataulpho de Paiva Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 IVAC – Institute of Vaccines and Medical Biologicals
2.11.1 IVAC – Institute of Vaccines and Medical Biologicals Details
2.11.2 IVAC – Institute of Vaccines and Medical Biologicals Major Business
2.11.3 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product and Services
2.11.4 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Queen Saovabha Mem. Inst
2.12.1 Queen Saovabha Mem. Inst Details
2.12.2 Queen Saovabha Mem. Inst Major Business
2.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccination Product and Services
2.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Microgen
2.13.1 Microgen Details
2.13.2 Microgen Major Business
2.13.3 Microgen Tuberculosis Vaccination Product and Services
2.13.4 Microgen Tuberculosis Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Tuberculosis Vaccination Breakdown Data by Manufacturer
3.1 Global Tuberculosis Vaccination Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Tuberculosis Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Tuberculosis Vaccination
3.4 Market Concentration Rate
3.4.1 Top 3 Tuberculosis Vaccination Manufacturer Market Share in 2021
3.4.2 Top 6 Tuberculosis Vaccination Manufacturer Market Share in 2021
3.5 Global Tuberculosis Vaccination Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Tuberculosis Vaccination Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tuberculosis Vaccination Market Size by Region
4.1.1 Global Tuberculosis Vaccination Sales in Volume by Region (2017-2028)
4.1.2 Global Tuberculosis Vaccination Revenue by Region (2017-2028)
4.2 North America Tuberculosis Vaccination Revenue (2017-2028)
4.3 Europe Tuberculosis Vaccination Revenue (2017-2028)
4.4 Asia-Pacific Tuberculosis Vaccination Revenue (2017-2028)
4.5 South America Tuberculosis Vaccination Revenue (2017-2028)
4.6 Middle East and Africa Tuberculosis Vaccination Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Tuberculosis Vaccination Sales in Volume by Type (2017-2028)
5.2 Global Tuberculosis Vaccination Revenue by Type (2017-2028)
5.3 Global Tuberculosis Vaccination Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Tuberculosis Vaccination Sales in Volume by Application (2017-2028)
6.2 Global Tuberculosis Vaccination Revenue by Application (2017-2028)
6.3 Global Tuberculosis Vaccination Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Tuberculosis Vaccination Sales by Type (2017-2028)
7.2 North America Tuberculosis Vaccination Sales by Application (2017-2028)
7.3 North America Tuberculosis Vaccination Market Size by Country
7.3.1 North America Tuberculosis Vaccination Sales in Volume by Country (2017-2028)
7.3.2 North America Tuberculosis Vaccination Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Tuberculosis Vaccination Sales by Type (2017-2028)
8.2 Europe Tuberculosis Vaccination Sales by Application (2017-2028)
8.3 Europe Tuberculosis Vaccination Market Size by Country
8.3.1 Europe Tuberculosis Vaccination Sales in Volume by Country (2017-2028)
8.3.2 Europe Tuberculosis Vaccination Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Tuberculosis Vaccination Sales by Type (2017-2028)
9.2 Asia-Pacific Tuberculosis Vaccination Sales by Application (2017-2028)
9.3 Asia-Pacific Tuberculosis Vaccination Market Size by Region
9.3.1 Asia-Pacific Tuberculosis Vaccination Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Tuberculosis Vaccination Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Tuberculosis Vaccination Sales by Type (2017-2028)
10.2 South America Tuberculosis Vaccination Sales by Application (2017-2028)
10.3 South America Tuberculosis Vaccination Market Size by Country
10.3.1 South America Tuberculosis Vaccination Sales in Volume by Country (2017-2028)
10.3.2 South America Tuberculosis Vaccination Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tuberculosis Vaccination Sales by Type (2017-2028)
11.2 Middle East & Africa Tuberculosis Vaccination Sales by Application (2017-2028)
11.3 Middle East & Africa Tuberculosis Vaccination Market Size by Country
11.3.1 Middle East & Africa Tuberculosis Vaccination Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Tuberculosis Vaccination Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Tuberculosis Vaccination and Key Manufacturers
12.2 Manufacturing Costs Percentage of Tuberculosis Vaccination
12.3 Tuberculosis Vaccination Production Process
12.4 Tuberculosis Vaccination Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Tuberculosis Vaccination Typical Distributors
13.3 Tuberculosis Vaccination Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 結核予防接種の世界市場2022：免疫ワクチン、治療ワクチン(Global Tuberculosis Vaccination Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

結核予防接種の世界市場2022：免疫ワクチン、治療ワクチン

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp